{"id":8088,"date":"2015-11-27T10:25:07","date_gmt":"2015-11-27T09:25:07","guid":{"rendered":"http:\/\/k2info.w.uib.no\/?p=8088"},"modified":"2015-11-27T10:43:00","modified_gmt":"2015-11-27T09:43:00","slug":"nye-forskernettverk-medisinsk-og-helsefaglig-forskning","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/nb_no\/2015\/11\/27\/nye-forskernettverk-medisinsk-og-helsefaglig-forskning\/","title":{"rendered":"[:no]Nye forskernettverk &#8211; medisinsk og helsefaglig forskning[:en]New research networks &#8211; medical and health research[:]"},"content":{"rendered":"<p>[:no]<img loading=\"lazy\" decoding=\"async\" class=\"\" src=\"http:\/\/www.cost.eu\/design\/cost\/images\/global\/logo_cost.png\" alt=\"COST | European Cooperation in Science and Technology\" width=\"306\" height=\"68\" \/><br \/>\nCOST er en europeisk nettverksorganisasjon der de fleste landene i Europa (herunder Norge og alle EU-landene) er medlemmer. En viktig oppgave for COST er \u00e5 fremme europeisk forskningssamarbeid ved \u00e5 igangsette vitenskapelige nettverk (&laquo;COST-aksjoner&raquo;).<!--more--><\/p>\n<p>Generell informasjon om COST kan finnes\u00a0<a href=\"http:\/\/www.forskningsradet.no\/no\/COST__Europeisk_forsknings_og_teknologisamarbeid\/1253984958631\" target=\"_blank\">her<\/a>\u00a0og <a href=\"http:\/\/www.cost.eu\/\" target=\"_blank\">her<\/a>.<br \/>\nI oktober 2015 ble det vedtatt \u00e5 igangsette 40 nye COST-aksjoner, hvorav f\u00f8lgende er innenfor\/relevante for medisinsk og helsefaglig forskning:<\/p>\n<p>\u00b7 European Medicines Shortages Research Network \u2013 addressing supply problems to patients <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15105\" target=\"_blank\">CA15105 &#8211; Medicines Shortages<\/a><\/p>\n<p>\u00b7 Diagnosis, Monitoring and Prevention of Exposure\u2010Related Noncommunicable Diseases <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15129\" target=\"_blank\">CA15129 &#8211; DiMoPEx<\/a><\/p>\n<p>\u00b7 Harmonising standardisation strategies to increase efficiency and competitiveness of European life\u2010science research\u00a0<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15110\" target=\"_blank\">CA15110 &#8211; CHARME<\/a><\/p>\n<p>\u00b7 Animal Behaviour Management and Training of Laboratory Non\u2010human Primates and Large Laboratory Animals\u00a0<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15131\" target=\"_blank\">CA15131 &#8211; PRIMTRAIN<\/a><\/p>\n<p>\u00b7 European Network on Myalgic Encephalomyelitis \/ Chronic Fatigue Syndrome <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15111\" target=\"_blank\">CA15111 &#8211; EUROMENE<\/a><\/p>\n<p>\u00b7 The comet assay as a human biomonitoring tool <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15132\" target=\"_blank\">CA15132 &#8211; hCOMET<\/a><\/p>\n<p>\u00b7 Functional Annotation of Animal Genomes \u2013 European network<br \/>\n<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15112\" target=\"_blank\">CA15112 &#8211; FAANG-Europe<\/a><\/p>\n<p>\u00b7 The Biogenesis of Iron\u2010sulfur Proteins: from Cellular Biology to Molecular Aspects <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15133\" target=\"_blank\">CA15133 &#8211; FeSBioNet<\/a><\/p>\n<p>\u00b7 Anti\u2010Microbial Coating Innovations to prevent infectious disease\u00a0<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15114\" target=\"_blank\">CA15114 &#8211; AMICI<\/a><\/p>\n<p>\u00b7 Multi\u2010target paradigm for innovative ligand identification in the drug discovery process <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15135\" target=\"_blank\">CA15135 &#8211; MuTaLig<\/a><\/p>\n<p>\u00b7 Open Multiscale Systems Medicine <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15120\" target=\"_blank\">CA15120 &#8211; OpenMultiMed<\/a><\/p>\n<p>\u00b7 European network to advance carotenoid research and applications in agro\u2010food and health <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15136\" target=\"_blank\">CA15136 &#8211; EUROCAROTEN<\/a><\/p>\n<p>\u00b7 A new Network of European BioImage Analysts to advance life science imaging <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15124\" target=\"_blank\">CA15124 &#8211; NEUBIAS<\/a><\/p>\n<p>\u00b7 European Network of Multidisciplinary Research and Translation of Autophagy knowledge <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15138\" target=\"_blank\">CA15138 &#8211; TRANSAUTOPHAGY<\/a><\/p>\n<p>\u00b7 Between Atom and Cell: Integrating Molecular Biophysics Approaches for Biology and Healthcare <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15126\" target=\"_blank\">CA15126 &#8211; MOBIEU<\/a><\/p>\n<p>Sammendrag av aksjonene kan finnes under lenkene og i vedlagte <a href=\"http:\/\/k2info.w.uib.no\/files\/2015\/11\/New-COST-Actions-Oct-2015_Medicine-health.pdf\" target=\"_blank\">fil<\/a>.<br \/>\nI vedlagte fil gis det ogs\u00e5 litt tilleggsinformasjon, samt en fullstendig liste over de nye COST-aksjonene.<\/p>\n<p>Norges forsknings\u00adr\u00e5d koordinerer prosessen med henblikk p\u00e5 norsk deltakelse i COST-aksjoner. Hans Hellebostad er kontaktperson for aksjonene innenfor medisin\/helse og kjemi. Ved interesse for \u00e5 delta bes man om \u00e5 ta kontakt med undertegnede innen 8. januar 2016. Man kan da ogs\u00e5 f\u00e5 mer detaljert informasjon om de enkelte aksjonene. <a href=\"http:\/\/k2info.w.uib.no\/files\/2015\/11\/S\u00f8knad-om-deltagelse-COST-aksjon.doc\" target=\"_blank\">S\u00f8knadsskjema<\/a> som brukes for \u00e5 kunne bli med som deltaker, f\u00f8lger vedlagt.<\/p>\n<p>Vennlig hilsen<br \/>\nHans Hellebostad<br \/>\nSenior Adviser<br \/>\nThe Research Council of Norway<br \/>\nDivision for Science\/Department for Medicine, Science and Technology<br \/>\nPhone + 47 22 03 71 72<br \/>\nE-mail: <a href=\"mailto:hh@rcn.no\">hh@rcn.no<\/a>[:en]<img loading=\"lazy\" decoding=\"async\" class=\"\" src=\"http:\/\/www.cost.eu\/design\/cost\/images\/global\/logo_cost.png\" alt=\"COST | European Cooperation in Science and Technology\" width=\"306\" height=\"68\" \/><br \/>\nCOST is a European networking organization in which most European countries (including Norway and all EU member states) are members. An important task for COST is to promote European research by initiating scientific networks (&laquo;COST actions&raquo;).<!--more--><\/p>\n<p>General information about COST can be found <a href=\"http:\/\/www.forskningsradet.no\/no\/COST__Europeisk_forsknings_og_teknologisamarbeid\/1253984958631\" target=\"_blank\">here<\/a> and <a href=\"http:\/\/www.cost.eu\/\" target=\"_blank\">here<\/a>.<br \/>\nIn October 2015 it was decided to initiate 40 new COST actions, of which the following is within \/ relevant for medical and health research:<\/p>\n<p>\u00b7 European Medicines Shortages Research Network \u2013 addressing supply problems to patients <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15105\" target=\"_blank\">CA15105 &#8211; Medicines Shortages<\/a><\/p>\n<p>\u00b7 Diagnosis, Monitoring and Prevention of Exposure\u2010Related Noncommunicable Diseases <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15129\" target=\"_blank\">CA15129 &#8211; DiMoPEx<\/a><\/p>\n<p>\u00b7 Harmonising standardisation strategies to increase efficiency and competitiveness of European life\u2010science research\u00a0<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15110\" target=\"_blank\">CA15110 &#8211; CHARME<\/a><\/p>\n<p>\u00b7 Animal Behaviour Management and Training of Laboratory Non\u2010human Primates and Large Laboratory Animals\u00a0<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15131\" target=\"_blank\">CA15131 &#8211; PRIMTRAIN<\/a><\/p>\n<p>\u00b7 European Network on Myalgic Encephalomyelitis \/ Chronic Fatigue Syndrome <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15111\" target=\"_blank\">CA15111 &#8211; EUROMENE<\/a><\/p>\n<p>\u00b7 The comet assay as a human biomonitoring tool <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15132\" target=\"_blank\">CA15132 &#8211; hCOMET<\/a><\/p>\n<p>\u00b7 Functional Annotation of Animal Genomes \u2013 European network<br \/>\n<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15112\" target=\"_blank\">CA15112 &#8211; FAANG-Europe<\/a><\/p>\n<p>\u00b7 The Biogenesis of Iron\u2010sulfur Proteins: from Cellular Biology to Molecular Aspects <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15133\" target=\"_blank\">CA15133 &#8211; FeSBioNet<\/a><\/p>\n<p>\u00b7 Anti\u2010Microbial Coating Innovations to prevent infectious disease\u00a0<a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15114\" target=\"_blank\">CA15114 &#8211; AMICI<\/a><\/p>\n<p>\u00b7 Multi\u2010target paradigm for innovative ligand identification in the drug discovery process <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15135\" target=\"_blank\">CA15135 &#8211; MuTaLig<\/a><\/p>\n<p>\u00b7 Open Multiscale Systems Medicine <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15120\" target=\"_blank\">CA15120 &#8211; OpenMultiMed<\/a><\/p>\n<p>\u00b7 European network to advance carotenoid research and applications in agro\u2010food and health <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15136\" target=\"_blank\">CA15136 &#8211; EUROCAROTEN<\/a><\/p>\n<p>\u00b7 A new Network of European BioImage Analysts to advance life science imaging <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15124\" target=\"_blank\">CA15124 &#8211; NEUBIAS<\/a><\/p>\n<p>\u00b7 European Network of Multidisciplinary Research and Translation of Autophagy knowledge <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15138\" target=\"_blank\">CA15138 &#8211; TRANSAUTOPHAGY<\/a><\/p>\n<p>\u00b7 Between Atom and Cell: Integrating Molecular Biophysics Approaches for Biology and Healthcare <a href=\"http:\/\/www.cost.eu\/COST_Actions\/ca\/CA15126\" target=\"_blank\">CA15126 &#8211; MOBIEU<\/a><\/p>\n<p>Summary of the actions can be found by following the links and the <a href=\"http:\/\/k2info.w.uib.no\/files\/2015\/11\/New-COST-Actions-Oct-2015_Medicine-health.pdf\" target=\"_blank\">attached file<\/a>. In the attached file is also provided some additional information and a complete list of the new COST actions.<br \/>\nThe Research Council of Norway is coordinating the process with regard to Norwegian participation in COST actions. I am contact person for actions in medicine \/ health and chemistry. If you are interested in participating, please contact me within 8 January 2016. Then you can also get more detailed information on individual actions. <a href=\"http:\/\/k2info.w.uib.no\/files\/2015\/11\/S\u00f8knad-om-deltagelse-COST-aksjon.doc\" target=\"_blank\">Application <\/a>for joining is enclosed.<\/p>\n<p>Regards<br \/>\nHans Hellebostad<br \/>\nSenior Adviser<br \/>\nThe Research Council of Norway<br \/>\nDivision of Science \/ Department of Medicine,<br \/>\nScience and Technology<br \/>\nPhone + 47 22 03 71 72 E-mail: <a href=\"mailto:hh@rcn.no\" target=\"_blank\">hh@rcn.no<\/a>[:]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:no] COST er en europeisk nettverksorganisasjon der de fleste landene i Europa (herunder Norge og alle EU-landene) er medlemmer. En viktig oppgave for COST er \u00e5 fremme europeisk forskningssamarbeid ved \u00e5 igangsette vitenskapelige nettverk (&laquo;COST-aksjoner&raquo;).<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/nb_no\/2015\/11\/27\/nye-forskernettverk-medisinsk-og-helsefaglig-forskning\/\">Read more &rarr;<\/a><\/p>\n","protected":false},"author":3238,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44],"tags":[64965],"class_list":["post-8088","post","type-post","status-publish","format-standard","hentry","category-nyheter","tag-64965"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/8088","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/users\/3238"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/comments?post=8088"}],"version-history":[{"count":6,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/8088\/revisions"}],"predecessor-version":[{"id":8108,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/posts\/8088\/revisions\/8108"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/media?parent=8088"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/categories?post=8088"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/nb_no\/wp-json\/wp\/v2\/tags?post=8088"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}